Hill Investment Group Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$339K Buy
369
+5
+1% +$5.07K 0.04% 41
2025
Q4
$391K Buy
364
+2
+0.6% +$1.91K 0.05% 39
2025
Q3
$276K Buy
362
+4
+1% +$2.98K 0.03% 47
2025
Q2
$279K Buy
358
+16
+5% +$12.4K 0.04% 43
2025
Q1
$282K Sell
342
-423
-55% -$352K 0.04% 40
2024
Q4
$591K Sell
765
-13
-2% -$10.8K 0.08% 42
2024
Q3
$711K Sell
778
-21
-3% -$18.9K 0.1% 36
2024
Q2
$702K Sell
799
-106
-12% -$84.8K 0.09% 37
2024
Q1
$704K Sell
905
-638
-41% -$454K 0.1% 39
2023
Q4
$899K Hold
1,543
0.13% 32
2023
Q3
$829K Buy
1,543
+50
+3% +$25.8K 0.14% 31
2023
Q2
$700K Hold
1,493
0.13% 35
2023
Q1
$513K Hold
1,493
0.1% 41
2022
Q4
$546K Buy
+1,493
New +$529K 0.13% 38

Other funds holding LLY

Hill Investment Group Partners's LLY Position: Q1 2026 in Review

Hill Investment Group Partners increased its Eli Lilly (LLY) stake by 1.4% in Q1 2026, buying an estimated $5.07K and bringing the position to 369 shares worth $339K. The position accounts for 0.04% of the portfolio, ranked #41.

Hill Investment Group Partners first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $899K in Q4 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hill Investment Group Partners held 369 shares of Eli Lilly worth $339K as of Q1 2026.
  • Hill Investment Group Partners bought 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.04% of Hill Investment Group Partners's portfolio in Q1 2026, its #41 holding.
  • Hill Investment Group Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Hill Investment Group Partners's Eli Lilly position peaked at $899K in Q4 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hill Investment Group Partners's 13F filing for Q1 2026, filed 12 May 2026.